StockData

ProPhase Labs, Inc. (PRPH) stock

PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.01−0.00 (-6.16%)

Close on Oct 19, 2026Market cap $119.68KP/E –Yield –

ProPhase Labs gross margin

Gross margin is gross profit as a percentage of revenue.

ProPhase Labs's gross margin for the twelve months ending Jun 30, 2026 was 16.8%. For fiscal 2025 it was 31.9%, against -2.2% the year before. The highest annual figure on record is 66.6% in fiscal 2013.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202531.9%+34.1
FY2024Dec 31, 2024-2.2%−46.7
FY2023Dec 31, 202344.5%−13.1
FY2022Dec 31, 202257.6%+4.5
FY2021Dec 31, 202153.1%+21.4
FY2020Dec 31, 202031.7%+5.3
FY2019Dec 31, 201926.5%−9.9
FY2018Dec 31, 201836.4%+16.7
FY2017Dec 31, 201719.7%−4.0
FY2016Dec 31, 201623.7%−9.3
FY2015Dec 31, 201533.0%−31.2
FY2014Dec 31, 201464.2%−2.4
FY2013Dec 31, 201366.6%+3.0
FY2012Dec 31, 201263.6%−1.0
FY2011Dec 31, 201164.6%+3.8
FY2010Dec 31, 201060.9%+2.5
FY2009Dec 31, 200958.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202622.4%−36.5
Q1 FY2026Mar 31, 202625.2%−11.5
Q4 FY2025Dec 31, 202531.5%+41.5
Q3 FY2025Sep 30, 2025-13.9%−29.1
Q2 FY2025Jun 30, 202558.9%+69.2
Q1 FY2025Mar 31, 202536.8%+39.3
Q4 FY2024Dec 31, 2024-10.0%+96.8
Q3 FY2024Sep 30, 202415.2%−12.6
Q2 FY2024Jun 30, 2024-10.3%−59.1
Q1 FY2024Mar 31, 2024-2.5%−57.0
Q4 FY2023Dec 31, 2023-106.9%−158.6
Q3 FY2023Sep 30, 202327.8%−21.7
Q2 FY2023Jun 30, 202348.8%−15.6
Q1 FY2023Mar 31, 202354.5%−5.8
Q4 FY2022Dec 31, 202251.7%−2.8
Q3 FY2022Sep 30, 202249.5%+7.6
Q2 FY2022Jun 30, 202264.3%+15.3
Q1 FY2022Mar 31, 202260.3%+2.0
Q4 FY2021Dec 31, 202154.5%+18.3
Q3 FY2021Sep 30, 202141.9%+14.7
Q2 FY2021Jun 30, 202149.1%+13.8
Q1 FY2021Mar 31, 202158.3%+36.4
Q4 FY2020Dec 31, 202036.2%+4.4
Q3 FY2020Sep 30, 202027.1%−3.0
Q2 FY2020Jun 30, 202035.3%+19.5
Q1 FY2020Mar 31, 202022.0%−0.5
Q4 FY2019Dec 31, 201931.8%−0.9
Q3 FY2019Sep 30, 201930.2%−0.8
Q2 FY2019Jun 30, 201915.8%−23.7
Q1 FY2019Mar 31, 201922.4%−19.4
Q4 FY2018Dec 31, 201832.8%+1.6
Q3 FY2018Sep 30, 201831.0%+16.8
Q2 FY2018Jun 30, 201839.5%+32.1
Q1 FY2018Mar 31, 201841.8%+30.8
Q4 FY2017Dec 31, 201731.1%−32.4
Q3 FY2017Sep 30, 201714.2%+0.2
Q2 FY2017Jun 30, 20177.3%–
Q1 FY2017Mar 31, 201711.0%–
Q4 FY2016Dec 31, 201663.5%–
Q3 FY2016Sep 30, 201614.1%–

More ProPhase Labs figures

See a number that looks wrong?